Iannone Robert 4
4 · Jazz Pharmaceuticals plc · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Award
Ordinary Shares
2024-01-17+5,970→ 51,322 total - Tax Payment
Ordinary Shares
2024-01-17$119.13/sh−1,730$206,095→ 49,592 total
Footnotes (3)
- [F1]Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified.
- [F2]The Reporting Person acquired 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 30, 2023.
- [F3]Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.